BDBM732866 2-(4,4-difluoroazepan-1-yl)-6,7-difluoro-N-(2-sulfamoylpyridine-4-yl)quinoline-3-carboxamide (KH17)::US20250115578, Example 17

SMILES NS(=O)(=O)c1cc(NC(=O)c2cc3cc(F)c(F)cc3nc2N2CCCC(F)(F)CC2)ccn1

InChI Key InChIKey=CWEGYKGIKUNUKW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 732866   

TargetSodium channel protein type 10 subunit alpha(Human)
Chengdu Kanghong Pharmaceutical

US Patent
LigandPNGBDBM732866(2-(4,4-difluoroazepan-1-yl)-6,7-difluoro-N-(2-sulf...)
Affinity DataIC50: 0.0950nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
Go to US Patent